News & Articles

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors

The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making

New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively

The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways

Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies

The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs